More than half of people getting a certain type of glaucoma surgery may suffer from temporary, sometimes severe vision loss afterwards, suggests a new study. A smaller proportion — about 8 in every 100 — could have some degree of permanent vision los…
Category: News
Short-Term Dark Adaptation May Be More Reliable In Identifying Primary Angle-Closure Suspects
Assessment of the anterior chamber angle configuration may be more reliable if performed after a short-term dark adaptation of 3 minutes, a study found.
Lucentis receives Health Canada approval for treatment of retinal vein occlusion
Following a priority review, Health Canada has approved Lucentis (ranibizumab) as a treatment for vision loss resulting from retinal vein occlusion (RVO). This makes Lucentis the first approved treatment of its class in Canada for this debilitating con…
Regeneron Announces Clinical Presentations At ASRS 2011 Annual Meeting
Regeneron Pharmaceuticals, Inc. (Nasdaq: REGN) announced that clinical data from four separate clinical studies of EYLEA™ (aflibercept injection) will be presented at the upcoming American Society of Retina Specialists (ASRS) meeting on Sunday, Augus…
Study Focuses On Relationship Between Glaucoma And Diabetes, Hypertension
Many Americans suffer from diabetes and hypertension and, according to a study by researchers at the University of Michigan Kellogg Eye Center, these individuals may have an increased risk of developing open-angle glaucoma (OAG). Joshua D. Stein, M.D.,…
LasikPlus® Invites You To Grand Re-Opening Event On August 19th At Rockville Center
LasikPlus®, a leading provider of laser vision correction, is hosting a Grand Re-Opening Event in its recently relocated Rockville Vision Center on Friday, August 19th from 11 a.m. to 2 p.m.
LasikPlus® Invites You To Grand Re-Opening Event On August 19th At Rockville Center
LasikPlus®, a leading provider of laser vision correction, is hosting a Grand Re-Opening Event in its recently relocated Rockville Vision Center on Friday, August 19th from 11 a.m. to 2 p.m.
Patients with diabetes, hypertension more likely to develop open-angle glaucoma
Many Americans suffer from diabetes and hypertension and, according to a study by researchers at the University of Michigan Kellogg Eye Center, these individuals may have an increased risk of developing open-angle glaucoma.
FDA Extends Target Date for Review of Eye Drug
Ruling on aflibercept for “wet” age-related macular degeneration may be delayed until November. Medscape Medical News
Medicare Debate: Cataract Surgery And Primary Care
John C. Goodman lists three ways for Medicare to save money (“Three Simple Ways Medicare Can Save Money,” op-ed, Aug. 11). Let’s add a fourth: Do away with all dollar-based deductibles and co-payments and replace them with percentage co-pays.
Eye Consultants Of Texas First In Dallas/Ft. Worth To Offer New Cataract Surgery Technology
Eye Consultants of Texas is the first ophthalmology practice in Dallas/Fort Worth to use the ORange®, the world’s first Intraoperative Wavefront Aberrometer that provides real-time measurements of the patient’s eye during cataract surgery. Prior to OR…
ISTA Pharmaceuticals To Present At Southern California Investor Conference And Stifel Nicolaus Annual Healthcare Conference
ISTA Pharmaceuticals, Inc. (NASDAQ: ISTA) today announced its executives will present at two conferences in August and September. Both conference presentations will be webcast and will be available at www.istavision.com.
Medicare Debate: Cataract Surgery And Primary Care
John C. Goodman lists three ways for Medicare to save money (“Three Simple Ways Medicare Can Save Money,” op-ed, Aug. 11). Let’s add a fourth: Do away with all dollar-based deductibles and co-payments and replace them with percentage co-pays.
Study Focuses On Relationship Between Glaucoma And Diabetes, Hypertension
Many Americans suffer from diabetes and hypertension and, according to a study by researchers at the University of Michigan Kellogg Eye Center, these individuals may have an increased risk of developing open-angle glaucoma (OAG).
HSS, pSivida enter orthopedic evaluation agreement
Drug delivery company pSivida Corp. today announced it has entered into an evaluation agreement with Hospital for Special Surgery (HSS), a world leader in orthopedics, rheumatology and rehabilitation, to investigate pSivida’s drug delivery technologies…
Regeneron Announces Review Of Biologics License Application For EYLEA? (aflibercept Injection) Extended By Three Months By FDA
Regeneron Pharmaceuticals, Inc. today announced that it has received notification from the U.S. Food and Drug Administration (FDA) that the agency has extended its target date to complete the priority review of the EYLEA Biologics License Application (…
ACS, 20 other organizations publish sixth edition of Physicians as Assistants at Surgery
In light of continuing Medicare and other third party-payer physician reimbursement issues and changes, the American College of Surgeons (ACS) and 20 other specialty surgical organizations have jointly published the sixth edition of Physicians as Assis…
Childhood Eye Tumor Made Up Of Hybrid Cells With Jumbled Development
A research team led by St. Jude Children’s Research Hospital scientists has identified a potential new target for treatment of the childhood eye tumor retinoblastoma. Their work also settles a scientific debate by showing the cancer’s cellular origins …
Tears Again® Advanced Liposome Spray Now Available At CVS
OCuSOFT, Inc., an ophthalmic research, development, and supply company is pleased to announce that Tears Again® advanced Liposome Spray, an adjunct to OCuSOFT® Lid Scrub Eyelid Cleansers, is now available nationwide at all CVS drug stores.
Aspheric Wavefront-Guided LASIK Boosts Near Vision In Hyperopic Presbyopes
Hyperopic LASIK with an aspheric ablation profile improved near vision in hyperopic presbyopes at 12 months, a study found.